Tennessee Valley VA Healthcare System, Nashville, TN, USA RUNX1 (AML1) is a gene that is frequently disrupted by chromosomal translocations in acute leukemia. Like its Drosophila homolog Runt, RUNX1 both activates and represses transcription. Both Runt and RUNX1 are required for gene silencing during development and a central domain of RUNX1, termed repression domain 2 (RD2), was defined as being required for transcriptional repression and for the silencing of CD4 during T-cell maturation in thymic organ cultures. Although transcriptional co-repressors are known to contact other repression domains in RUNX1, the factors that bind to RD2 had not been defined. Therefore, we tested whether RD2 contacts histone-modifying enzymes that may mediate both repression and gene silencing. We found that RD2 contacts SUV39H1, a histone methyltransferase, via two motifs and that endogenous Suv39h1 associates with a Runx1-regulated repression element in murine erythroleukemia cells. In addition, one of these SUV39H1-binding motifs is also sufficient for binding to histone deacetylases 1 and 3, and both of these domains are required for full RUNX1-mediated transcriptional repression. The association between RUNX1, histone deacetylases and SUV39H1 provides a molecular mechanism for repression and possibly gene silencing mediated by RUNX1.
RUNX1 (AML1) is a gene that is frequently disrupted by chromosomal translocations in acute leukemia. Like its Drosophila homolog Runt, RUNX1 both activates and represses transcription. Both Runt and RUNX1 are required for gene silencing during development and a central domain of RUNX1, termed repression domain 2 (RD2), was defined as being required for transcriptional repression and for the silencing of CD4 during T-cell maturation in thymic organ cultures. Although transcriptional co-repressors are known to contact other repression domains in RUNX1, the factors that bind to RD2 had not been defined. Therefore, we tested whether RD2 contacts histone-modifying enzymes that may mediate both repression and gene silencing. We found that RD2 contacts SUV39H1, a histone methyltransferase, via two motifs and that endogenous Suv39h1 associates with a Runx1-regulated repression element in murine erythroleukemia cells. In addition, one of these SUV39H1-binding motifs is also sufficient for binding to histone deacetylases 1 and 3, and both of these domains are required for full RUNX1-mediated transcriptional repression. The association between RUNX1, histone deacetylases and SUV39H1
Introduction
Translocations that disrupt the RUNX1 gene are among the most common aberrations found in human leukemia. The t(8;21) is found in 10-15% of myeloid leukemia and gives rise to a fusion protein that contains the N-terminal portion of RUNX1 fused to nearly all of myeloid translocation gene on chromosome 8 (MTG8, also known as eight-twenty-one (ETO)) (Miyoshi et al., 1991 (Miyoshi et al., , 1993 Erickson et al., 1994) . The fusion protein appears to function as a transcriptional repressor of RUNX1-regulated genes (Peterson and Zhang, 2004) . The t(12;21) is found in up to 25% of pediatric B-cell acute leukemia and creates a chimeric gene encoding the TEL-RUNX1 fusion protein (Golub et al., 1995; Nucifora et al., 1995; Raynaud et al., 1995; Romana et al., 1995) . TEL-RUNX1 also appears to act as a transcriptional repressor that dominantly interferes with RUNX1-specific transactivation (Hiebert et al., 1996; Chakrabarti and Nucifora, 1999; Fenrick et al., 2000; Guidez et al., 2000) . RUNX1 function is also impaired by the inv(16), which fuses the RUNX1 associating factor, core binding factor b (CBFb or polyoma enhancer binding protein 2 beta) to the smooth muscle myosin heavy-chain gene MYH11, in approximately 8% of acute myeloid leukemia (Liu et al., 1993) . Like the t(8;21) and the t(12;21), the inv(16) also encodes a transcriptional repressor, but this factor must associate with RUNX1 to regulate transcription (Lutterbach et al., 1999; Durst et al., 2003) .
RUNX1 is a member of the mammalian Runt domain family of transcription factors, which were recently renamed the RUNX factors after the Runt protein that controls segmentation in the Drosophila embryo (Gergen and Wieschaus, 1985; van Wijnen et al., 2004) . Runt either activates or represses transcription in a promoteror enhancer-specific context and cell type-specific manner, but more frequently it is required for repressing transcription (Wheeler et al., 2002; Swantek and Gergen, 2004) . For instance, during embryogenesis the establishment of Runt-mediated repression of engrailed is dependent on the dosage of the zinc-fingercontaining transcription factor Tramtrack. However, the maintenance of repression of engrailed is dependent on the presence of the Groucho and dCtBP co-repressors and the Rpd3 histone deacetylase (Wheeler et al., 2002) . Thus, Runt acts in a context-dependent manner, activating or repressing gene expression depending on the constitution of a particular promoter/enhancer or the availability of a given co-factor in a specific cell type.
Likewise, RUNX1 acts as an 'organizing' factor for many promoters and enhancers. RUNX1 is a poor activator of transcription when expressed alone or when tested using artificial promoters containing multiple RUNX-binding sites. However, in concert with other DNA-binding factors, RUNX family members cooperate to activate transcription (Zhang et al., 1996; Britos-Bray and Friedman, 1997; Goetz et al., 2000; Gu et al., 2000; Cameron and Neil, 2004) . By contrast, RUNX1 is a potent transcriptional repressor, even when expressed alone, albeit in a cell type-specific manner. In fact, three distinct domains, termed repression domains 1, 2 and 3, are required for RUNX1-mediated repression (Aronson et al., 1997; Lutterbach et al., 2000) . RUNX1 recruits the mSin3A co-repressor through a domain adjacent to the DNA-binding domain (repression domain 1) (Lutterbach et al., 2000) . In addition, RUNX1 contacts Groucho family members to repress transcription in a promoter-dependent manner through a C-terminal motif termed repression domain 3 (Aronson et al., 1997; Levanon et al., 1998; Javed et al., 2000; Lutterbach et al., 2000; Nishimura et al., 2004) . Repression domain 2 was simply defined as an approximately 100 amino-acid sequence that was required for repression (Lutterbach et al., 2000) .
In addition to transcriptional repression, genetic studies have implicated Runx1 and Runx3 in the silencing of gene transcription. During T-cell development, CD4 and CD8 are silent in immature T-cells (CD4 À /CD8 À ), and after these cell surface markers expressed either are CD4 or CD8 are silenced as T-cells move from the 'double-positive' to the 'single-positive' stage (e.g. CD4 À /CD8 þ ). Using site-directed mutagenesis of the CD4 silencer elements in transgenic mouse studies, binding sites for Runx family members were found to be necessary for silencing CD4 expression. Moreover, mice lacking expression of Runx1 in T-cells failed to establish CD4 silencing in immature T-cells, whereas mice lacking Runx3 failed to maintain silencing of CD4 in cytotoxic T-cells (Taniuchi et al., 2002) . Conversely, Runx2 was not required for the silencing of CD4, even though it may be expressed in T-cells. Thus, there may be differences between the factors that the Runx family members recruit to repress and/or silence transcription.
The development of an in vitro-based system for studying the mechanism of RUNX1-mediated silencing of CD4 allowed the demonstration that repression domains 1 and 3 were dispensable for silencing of CD4, but that repression domain 2 (RD2) was required for silencing of CD4 (Telfer et al., 2004) . Given the roles of RUNX family members in both establishment and maintenance of repression, as well as gene silencing during T-cell development, we hypothesized that RUNX1 and RUNX3 may associate with factors that regulate the 'histone code' (Durst et al., 2003) . The histone code hypothesis suggests that deacetylation of key lysine residues in the conserved tails of histones is followed by methylation that allows the association of silencing factors such as heterochromatin protein-1 (HP1), which binds to methylated histone H3 (Firestein et al., 2000; Jacobs et al., 2001; Jenuwein and Allis, 2001; Lachner et al., 2001) . Therefore, we asked whether SUV39H1, a histone H3 lysine 9-specific methyltransferase (Rea et al., 2000) , and histone deacetylases contact RUNX1 within RD2 or other domains that are known to be required for transcriptional repression and gene silencing. We found that both SUV39H1 and histone deacetylase-1 and -3 contacted RUNX1 within RD2. Deletion of either of the two SUV39H1 contact sites or the HDAC-binding motif within repression domain 2 of RUNX1 significantly impaired RUNX1-mediated transcriptional repression. In addition, RUNX1 and RUNX3, but not Runx2, associated with SUV39H1 and Runx1 recruited Suv39h1 to an endogenous target gene, which raises the possibility that recruitment of histone methyltransferases contributes to RUNX1-mediated silencing of gene expression.
Results

RUNX1 and RUNX3 associate with SUV39H1
As RUNX1 and RUNX3 both contribute to gene silencing of CD4 at distinct stages of T-cell development (Taniuchi et al., 2002) , we tested whether RUNX family members could associate with SUV39H1. Each RUNX family protein was co-expressed with epitope-tagged SUV39H1 (FLAG-SUV39H1), SUV39H1 was immunoprecipitated, and the co-purifying RUNX proteins detected by immunoblot analysis (Figure 1a ). Both RUNX1 and RUNX3, which are required for CD4 silencing, associated with SUV39H1 ( Figure 1a ). By contrast, Runx2, which does not contribute to CD4 gene silencing, did not co-purify with SUV39H1 under these conditions ( Figure 1a ). In addition, using these same conditions we were unable to detect an association between RUNX1 and HP1, which associates with SUV39H1 (Lachner et al., 2001 ) (data not shown), suggesting that SUV39H1 contacts RUNX1 and RUNX3 specifically.
Independently, this same interaction was identified, but it was found that when SUV39H1 was overexpressed, it contacted the Runt domain and inhibited the ability of RUNX1 to bind to DNA in vitro, thus creating an apparently inactive complex (Chakraborty et al., 2003) . Given that the Runt domains of the RUNX family members are nearly identical, the association between SUV39H1 and RUNX1 and RUNX3, but not RUNX2, suggested that a domain(s) outside the Runt domain must contribute to or mediate the association with SUV39H1. In addition, the levels of SUV39H1 are very low in many cell types that express RUNX1 or RUNX3 at high levels. Thus, it seemed possible that there would not be enough SUV39H1 in most cell types to inhibit RUNX1 DNA-binding functions. Therefore, we asked whether additional complexes between RUNX1 and SUV39H1 might be present in cells that could contact DNA and mediate transcriptional repression. We used DNA affinity chromatography to purify endogenous RUNX1 from Jurkat T cells and asked whether SUV39H1 co-purified. In numerous experiments we consistently observed more SUV39H1 in the eluate from the RUNX DNA affinity column than from a non-specific DNA control column (Figure 1b) . However, there was often background contamination from our control DNA-binding site column, possibly reflecting the ability of SUV39H1 to associate with many DNA-binding factors that contact DNA nonspecifically (e.g. histones).
Identification of the RUNX1: SUV39H1 interaction domain The observation that SUV39H1 might contact RUNX1 in a manner that allowed RUNX1 to still contact DNA and the finding that RUNX2 failed to associate with SUV39H1 encouraged us to ask whether SUV39H1 might contact RUNX1 within the C-terminal repression domains by using previously created C-terminal deletion mutants (Figure 2a ) (Lutterbach et al., 2000) . These deletion mutants all retain the Runt domain, which is required for DNA binding and nuclear localization. Each RUNX1 mutant was co-expressed with FLAG-SUV39H1 and cell lysates were immunoprecipitated with anti-FLAG crosslinked to sepharose beads to avoid interfering immunoglobulin heavy-chain reactivity with the secondary antibody. As a control, RUNX1 was expressed in the absence of SUV39H1 (Figure 2b , lane labeled RUNX1 Con). RUNX1 was immunoprecipitated using anti-FLAG, only when FLAG-SUV39H1 was co-expressed ( Figure 2b ). In addition, deletion of residues 469-480 (RD3) did not affect the association with SUV39H1. However, a deletion of RD2, residues 290-432, appeared to significantly reduce the association between RUNX1 and SUV39H1 ( Figure 2b ), although it retained some ability to copurify, likely due to the association between SUV39H1 and the RUNX1 DNA-binding domain (Chakraborty et al., 2003) . Thus, RUNX1 may contact SUV39H1 through multiple domains, one of which lies within a previously identified repression domain (residues 290-432) (Lutterbach et al., 2000) . , or RUNX3 were co-expressed with or without FLAG-SUV39H1. 40 h after transfection, cell lysates were prepared in PBS containing 0.5% Triton X-100, 0.1% sodium deoxycholate, 0.1% sodium dodecyl sulfate (SDS), and SUV39H1 was immunoprecipitated with anti-FLAG agarose beads. Co-purifying RUNX proteins were detected with antibodies specific to each family member. (b) RUNX1 associates with SUV39H1 in Jurkat T cells. RUNX1 was purified using DNA affinity chromatography and the eluate analysed for RUNX1 or SUV39H1 by immunoblot analysis. Control, a DNA binding site for T cell factors was used as a nonspecific control.
RUNX1 recruits histone-modifying enzymes E Reed-Inderbitzin et al
The possibility of multiple contact sites in RUNX1 for recruitment of SUV39H1 diminishes the effectiveness of deletion-mapping studies. Therefore, we created a series of GAL4-RUNX1 fusion proteins to define the domains in RUNX1 that are sufficient for associating with SUV39H1 ( Figure 3a) . The GAL4 DNA-binding domain is especially useful for these studies as it functions as an epitope tag and contains a nuclear localization signal. The initial deletion studies suggested the presence of SUV39H1-binding sites in both the N-terminal and C-terminal portions of RUNX1. Therefore, GAL4-RUNX1 fusion proteins spanning the first 250 amino acids (aa) of RUNX1 were tested by coexpression with FLAG-SUV39H1, immunoprecipitation, and immunoblot analysis to detect the purified proteins ( Figure 3b , left-hand panels). As expected, the GAL4 DNA-binding domain did not associate with SUV39H1 and served as a negative control. Also, residues 210-250 of RUNX1 were not sufficient to mediate an association with SUV39H1. By contrast, fusion proteins containing either residues 1-170 or residues 172-212 of RUNX1 were sufficient to co-purify with SUV39H1.
Next, we sought to define the motifs in the C-terminus of RUNX1 that are sufficient to contact SUV39H1. GAL4 fusion proteins were constructed that span the region between residues 210 and 480 of RUNX1 ( Figure 3a ) and tested for SUV39H1 recruitment by co-purification as described above. RUNX1 residues 210-290, 290-351 and 432-480 failed to associate with SUV39H1 under these conditions (Figure 3b , middle and right-hand panels). By contrast, sequences that were previously defined as required for RUNX1-dependent transcriptional repression (residues 351-381 and 380-430) were sufficient to co-purify with SUV39H1 ( Figure 3b , middle and right panels, note that GAL4-290-351 migrates above the light-chain band, lower panel, to allow a clear determination of binding). The observation that residues 351-381 could contact SUV39H1 was consistent with the initial deletion analysis in which the 1-290/351-381 mutant associated with SUV39H1 ( Figure 2b) . Thus, at least four motifs of RUNX1 can contact SUV39H1.
SUV39H1 associates with RUNX1 through multiple domains
The observation that multiple domains of RUNX1 contact SUV39H1 raised the possibility that more than one domain of SUV39H1 might contact RUNX1. To test this possibility, we fused fragments of SUV39H1 to the GAL4 DNA-binding domain ( Figure 4a ) and co-expressed these epitope-tagged proteins with RUNX1. After immunoprecipitation using anti-GAL4, co-purifying RUNX1 was detected by immunoblot analysis. Both N-terminal (DSet) and C-terminal domains (242-412) of SUV39H1 were sufficient to contact RUNX1 (Figure 4b , upper right-hand panel), which is consistent with multiple contact sites for SUV39H1 on RUNX1. However, we consistently observed that deletion of the first 104 aa of SUV39H1 impaired the association with RUNX1 (Figure 4b , third lane, upper right-hand panel). Thus, it is possible that the Nterminus contains sequences that contribute to RUNX1 binding or that this mutant assumes a conformation that does not associate as well with RUNX1.
Next, we attempted to extend this mapping to an in vitro system. We expressed GST-SUV39H1 fusion proteins in bacteria and used glutathione agarose beads containing these fusion proteins to purify 35 S-labeled RUNX1 or RUNX1a (an isoform containing essentially the first 250 aa of RUNX1) that were synthesized by in vitro transcription and translation. Both RUNX1 and RUNX1a associated with GST-SUV39H1 when compared to GST alone. Although we consistently observed some background with RUNX1 on the GST-containing beads (Figure 4c ), more of the 480 aa isoform as compared to the 250 aa isoform (RUNX1a) was consistently precipitated from the lysates by GST-SUV39H1. However, the majority of this association was lost when GST-DSet or GST-243-412 were used in the binding assay (Figure 4c ), although we did observe somewhat more binding of RUNX1 to GST-DSet over GST or GST-242-412. Upon longer exposure, we also RUNX1 recruits histone-modifying enzymes E Reed-Inderbitzin et al observed a small amount of binding of RUNX1a to both of the SUV39H1 deletion mutants, which appeared to be specific, as there was no background in the corresponding GST lane (data not shown).
Histone deacetylases also contact RD2
In addition to the association between SUV39H1 and RUNX1, RUNX1 can bind to HDAC1, HDAC3 and HDAC9 and to a lesser degree HDAC2, HDAC5 and HDAC6 (Durst et al., 2003) . Therefore, we tested whether HDAC1 or HDAC3 might also contact the motifs that are required for repression within RD2 by screening these factors against the collection of GAL4-RUNX1 fusion proteins. Both HDAC1 and HDAC3 associated with residues 380-432 when linked to GAL4, but not with residues 351-381, 290-350 or 432-480 ( Figure 5 ). Given that this motif also was sufficient to bind to SUV39H1, this sequence may contain two binding sites for histone-modifying enzymes, or SUV39H1 and HDACs may form a complex that can contact this domain. Given that the sequences between RUNX1 residues 350-432 within RD2 contain two motifs that are sufficient for contacting SUV39H1, one of which binds both HDAC1 and HDAC3, we created smaller deletions within this region to further explore the function of these subdomains. As SUV39H1 contacts residues 351-381 and this sequence lies within a region of RUNX1 that is required for silencing of CD4 in thymic organ cultures (Telfer et al., 2004) , we deleted this region up to residue 387 to match the mutation assessed in the thymic organ culture studies (D347-387, Figure 6a ) (Telfer et al., 2004) . In addition, we deleted the domain that was sufficient to contact all three of these factors (D379-430). When these mutants were co-expressed with HDAC1 or HDAC3, co-immunoprecipitation analysis The GAL4 DNA binding domain (residues 1-147), GAL4-SUV39H1 or the indicated mutants were co-expressed with RUNX1 in Cos7L cells and immuno-purified using anti-GAL4 beads. Co-purifying RUNX1 was detected by immunoblot analysis with anti-RUNX1. (c) RUNX1 binds to SUV39H1 in vitro. RUNX1 or the 250 aa isoform RUNX1a were transcribed and translated in reticulocyte lysates and affinity purified using glutathione-agarose beads containing the GST-SUV39H1 fusion proteins indicated below each panel. TnT, unfractionated transcribed and translated RUNX1 proteins.
RUNX1 recruits histone-modifying enzymes E Reed-Inderbitzin et al indicated that D347-387 retained the ability to bind to HDAC3 as expected, but that HDAC1 was severely impaired in its ability to associate with this mutant (Figure 6b , upper panels). By contrast, neither HDAC was able to bind to the mutant lacking residues 379-430. For SUV39H1, our initial analysis suggested that the 351-381 motif of RUNX1 required higher levels of expression to co-purify with SUV39H1 than did residues 380-432 (Figure 2) . Consistent with this observation, the D379-430 mutant was severely impaired for binding to SUV39H1 (Figure 6c ), whereas 347-387 was still able to associate with SUV39H1 to some degree. In this assay, we also included an additional mutation, which deletes the region between residues 290 and 387 (D290-387). This mutant, similar to D347-387, was impaired in association with SUV39H1, but not to the degree of 379-430.
To begin to dissect the function of the subdomains that contact HDACs and SUV39H1, we performed reporter assays using the p21 cyclin-dependent kinase inhibitor promoter linked to firefly luciferase, which contains multiple RUNX1-binding sites (Lutterbach et al., 1999; Durst et al., 2003) . RUNX1 was able to repress this promoter up to five-fold in the absence of its co-factor CBFb, and the co-expression of CBFb stimulated RUNX1-mediated repression to nearly 10-fold (Figure 6d ). By contrast, deletion of residues 347-387 or 379-430 impaired RUNX1-mediated repression (Figure 6d ). The inclusion of CBFb in these assays did augment the action of these deletion mutants, but they were still impaired relative to the wild-type protein.
Thus, each subdomain that contacts SUV39H1 and/or HDAC1 or HDAC3 is required for RUNX1-mediated repression.
Suv39h1 associates with a RUNX1-regulated repression element
The observation that RUNX1 is required for gene silencing (Taniuchi et al., 2002) , together with the established role of SUV39H1 in transcriptional silencing, and our observation that SUV39H1 can be purified RUNX1 recruits histone-modifying enzymes E Reed-Inderbitzin et al using RUNX1 DNA-binding sites (Figure 1b) , suggested that Suv39h1 may be recruited to RUNX1-regulated genes to mediate repression and/or gene silencing. Although CD4 would be an ideal target to assess the recruitment of Suv39h1, an appropriate cell model is not available for this analysis. However, the Band 3 upstream regulatory element (B3URE) contains five consensus RUNX1-binding sites and mediates RUNX1-dependent repression of Band 3 in murine erythroleukemia (MEL) cells (J Xie and SJ Brandt, in preparation). Therefore, we asked whether Suv39h1 could associate with this control region using biotinylated double-stranded oligonucleotides derived from the B3URE, which contain two of the RUNX1-binding sites. We found that both RUNX1 and CBFb were enriched when wild-type sequences were used, with only modest or no binding when the RUNX1 sites were mutated ( Figure 7a ). Although some non-specific binding of Suv39h1 was observed, endogenous Suv39h1 was greatly enriched using the B3URE-containing wild-type RUNX1-binding sites (Figure 7a ). Finally, we confirmed that Suv39h1 associates with the B3URE in MEL cells in which Band 3 expression is suppressed using chromatin immunoprecipitation. Whereas control IgG did not immunoprecipitate the B3URE, anti-Suv39h1 was able to dramatically enhance the amount of B3URE immunoprecipitated (Figure 7b and c), indicating that Suv39h1 associates with this regulatory element.
Discussion
RUNX1 and RUNX3 both activate and repress transcription depending on the cellular or gene context. During T-cell development, these factors are required for the silencing of CD4 (Taniuchi et al., 2002) . These factors can associate with the mSin3 and Groucho corepressors, but it appears that repression domain 2 is critical for RUNX1-mediated silencing of CD4 (Telfer et al., 2004) . Thus, our identification of two SUV39H1 contact points within repression domain 2 of RUNX1, with one of these RUNX1 domains also contacting HDAC1 and HDAC3, begins to provide a mechanistic basis for gene silencing mediated by RUNX1. The recent identification of Band 3 as a target for repression by RUNX1 (J Xie and SJ Brandt, in preparation) has allowed us to confirm that Suv39h1 is associated with a silencing element that is controlled by RUNX1. Co-repressors often associate with target proteins through multiple interaction domains and it is often the case that each contact point with the target factor is critical for full activity. This may be due to the need to create the correct context, conformation or spacing for the associated histone-modifying enzymes to function. For example, ETO/MTG8 contains multiple contact sites for mSin3, nuclear hormone co-repressors and histone deacetylases (Lutterbach et al., 1998b; Amann et al., 2001; Hildebrand et al., 2001 ), but mutation of only one site can significantly impair RUNX1-ETOmediated repression (Lutterbach et al., 1998b; Amann et al., 2001) . In fact, a completely inactive form of RUNX1-ETO retains the ability to bind to the nuclear hormone co-repressor N-CoR and histone deacetylase-1 (Lenny et al., 1995; Amann et al., 2001) . Our mutagenesis study indicates that elimination of residues 379-430 or 347-387 impaired RUNX1-mediated repression. While the deletion of residues 379-430 impaired the association of SUV39H1, HDAC1 and HDAC3, the deletion of residues 347-387 did not greatly impact binding to HDAC3, but affected HDAC1 association ( Figure 6 ). It is notable that the D347-387 and D379-430 deletions overlap by 7 aa, which might suggest that HDAC1 binds to the N-terminal portion of the 380-432 fragment ( Figure 5 ). Nevertheless, we conclude that simply associating with co-repressors and histonemodifying enzymes is not sufficient for RUNX1-mediated repression and perhaps gene silencing, because all of these mutants retain the ability to interact with mSin3 and Groucho (Aronson et al., 1997; Lutterbach et al., 2000) and their associated histone-modifying enzymes.
Thymic organ cultures were used to determine that silencing of CD4 required RUNX1 sequences between residues 290 and 387, but also indicated that the C-terminal 90 aa as well as residues 239-289 contributed to silencing (Telfer et al., 2004) . This latter domain is adjacent to sequences that are required for RUNX1 to contact mSin3A, but deletion of residues 180-210 in murine Runx1, which is analogous to the deletion of residues 208-237 in human RUNX1 that impaired mSin3A association (Lutterbach et al., 2000) , had little, RUNX1 recruits histone-modifying enzymes E Reed-Inderbitzin et al if any, effect on silencing of CD4 (Telfer et al., 2004) . However, the sequences that mediate the association with mSin3A have not been pinpointed and it remains possible that disruption of residues 239-289 may also affect the association with this co-repressor as phosphorylation of residues in this domain affected mSin3A association (Lutterbach et al., 2000; Imai et al., 2004) . Also, the initial studies were performed in high concentrations of detergent (Lutterbach et al., 2000) , leaving open the possibility that mSin3A may bind a second domain within RUNX1. Alternatively, differences between the murine and human RUNX1 may account for differences in the requirement of these sequences for RUNX1 action. Further analysis of mSin3A binding will be required to determine whether it contributes to silencing of CD4 or whether another cofactor also is required for RUNX1 to act.
In our analysis, residues 380-432 (within the Cterminal 100 aa) were sufficient for binding to SUV39H1, HDAC1 and HDAC3, and deletion of these sequences impaired the association with these factors and repression. Given the tight links between histone deacetylation, histone methylation of H3 lys 9 and gene silencing (Jenuwein and Allis, 2001) , it is somewhat unexpected that deletion of this domain only modestly affected silencing of CD4 (Telfer et al., 2004) . However, given that removal of the C-terminal 90 aa only removes one SUV39H1-binding site and that this mutant retains the ability to recruit mSin3A and its associated histone deacetylases, it is possible that, in overexpression assays, this mutant retains sufficient activity to silence CD4.
In addition to residues 380-432, a second motif within repression domain 2 that was sufficient to contact SUV39H1 and that was required to bind to HDAC1 is residues 351-381, which were identified as critical for RUNX1-mediated gene silencing (Telfer et al., 2004) . While the simple interpretation of this result is that SUV39H1 and perhaps HDAC1 recruitment are critical for RUNX1-mediated repression, and possibly silencing of CD4, this motif is also sufficient to target a heterologous protein to the nuclear matrix (Kanno et al., 1998; Zeng et al., 1998) . The dual function for this motif clouds the interpretation of this result, but this domain does not appear to be absolutely required to direct RUNX1 to the nuclear matrix, as RUNX1 may contain a second nuclear matrix targeting domain (Kanno et al., 1998) . Thus, the loss of transcriptional repression upon deletion of residues 347-387 may be due to disrupting the conformation or stability of the histone-modifying complex, rather than inappropriate subnuclear localization. Conversely, our work raises the possibility that the nuclear matrix targeting that is mediated by residues 351-381 may be due to the association with SUV39H1.
RUNX1 activates transcription by associating with multiple classes of DNA-binding transcription factors. Most of these interactions are mediated by sequences in the N-terminus of RUNX1 or the Runt domain. We have mapped two SUV39H1-binding sites to these same domains (residues 1-170 and 172-212), which is consistent with previous results (Chakraborty et al., 2003) .
Thus, it is possible that SUV39H1 competes for these sites on RUNX1 with activating factors and provides a molecular switch for turning RUNX1 into a transcriptional repressor. Alternatively, RUNX1 may have promoter/enhancer-specific functions dependent on the context of the RUNX1-binding sites. In addition, our data raise the possibility that RUNX1 forms two distinct complexes with SUV39H1, one that contacts DNA to silence gene expression in addition to the complex that cannot bind to DNA (Chakraborty et al., 2003) .
By defining multiple binding sites within RUNX1 for SUV39H1, our work also implicates SUV39H1 as an important effector of transcriptional repression or gene silencing mediated by the chromosomal translocation fusion proteins generated by the t(12;21), t(8;21), and the inv(16). The t(12;21) fusion protein retains nearly all of RUNX1 and, therefore, was predicted to contact SUV39H1. We have confirmed that it does indeed associate with SUV39H1. However, TEL contributes repression domains to this fusion protein, which limits our ability to determine whether SUV39H1 recruitment contributes to repression (Reed-Inderbitzin and Hiebert, unpublished data). RUNX1 residues 1-204 are also retained in the t(8;21) fusion protein, which again predicts that this fusion protein can recruit SUV39H1, although this association may negatively affect DNA binding (Chakraborty et al., 2003) . Although the inv(16) contains no homology to RUNX1, it acts as a corepressor for RUNX1 (Lutterbach et al., 1999; Durst et al., 2003) . Our initial analysis failed to detect an association between SUV39H1 and the inv(16) fusion protein. However, it remains possible that this fusion protein stabilizes the interaction between RUNX1 and SUV39H1. Given the tight links between histone deacetylation, methylation and gene silencing, it is possible that inhibitors of this histone methyltransferase and/or histone deacetylases may have therapeutic potential for the leukemia containing disruptions of RUNX1.
Materials and methods
Cell culture and plasmids Cos-7 cells were maintained in Dulbecco's modified Eagle medium (DMEM, BioWhittaker Inc., Walkersville, MD, USA) containing 10% fetal bovine serum, 50 U/ml penicillin, 50 mg/ml streptomycin and 2 mM L-glutamine (BioWhittaker). NIH 3T3 cells were maintained in DMEM containing 10% bovine serum. Jurkat cells were cultured in RPMI 1640 (BioWhittaker) containing 10% fetal bovine serum, antibiotics and L-glutamine. pCMV5-RUNX1 and deletion plasmids have been previously described (Lutterbach et al., 2000) , with the exception of the D347-387 and D379-430 mutants. These latter plasmids were created by polymerase chain reaction (PCR) by amplifying sequences including residues 1-347 and subcloning this fragment into the BglII site in RUNX1 D290-387. The D379-430 deletion was created by PCR amplification of the 1-379 and 430-480 fragments with the inclusion of a unique NheI restriction site for cloning. Other deletions and small fragments that were fused to the GAL4 DNA-binding domain were created by PCR. The GAL4 fusion cDNAs were prepared by subcloning the indicated fragments, in frame, with the GAL4 DNA-binding domain (1-147) using the pCMV-M series vectors (Amann et al., 2001 ).
Co-immunoprecipitations and immunoblotting
Cos-7 cells (3 Â 10 6 cells in 100 mm dishes) were transfected using lipofectamine or lipofectamine 2000 (Invitrogen, Carlsbad, CA) with up to 5 mg of expression plasmids. Cells were extracted with phosphate-buffered saline supplemented with 1 mM ethylenediamine tetraacetate (EDTA), 1.5 mg/ml iodoacetamide, 0.2 mM polymethyl sulfonyl fluoride (PMSF) and 0.1 T.I.U/ml aprotinin, and containing 0.5% Triton X-100 unless otherwise noted as described (Amann et al., 2001) . Immunoblot analysis was performed as described (Lutterbach et al., 1998a (Lutterbach et al., , 2000 Amann et al., 2001) . Antibodies to CBFb, RUNX1, RUNX2 and RUNX3 are available from EMD Biosciences, San Diego, CA. Anti-SUV39H1 has been described previously (Firestein et al., 2000) . Anti-GAL4and Anti-FLAG were purchased from Sigma (St Louis, MO, USA).
In vitro purification studies were performed using the bacterially expressed GST-fusion proteins, which were created by subcloning the full-length SUV39H1 or the DSet and 243-412 fragments from the GAL4 plasmids into pGEX4T. The purified proteins were quantified after sodium dodecyl sulfate (SDS)-PAGE using Coomassie Brilliant Blue, and approximately equal amounts of protein were used for each reaction. RUNX1 or RUNX1a was transcribed and translated using the quick coupled system (TnT; Promega, Inc., Madison, WI, USA) in the presence of 35 S-methionine. An equal amount of the reticulocyte lysate was diluted into PBS containing 0.5% Triton X-100 and added to the glutathione beads and incubated on ice for 4-12 h. Samples were washed three times with PBS containing 0.5% Triton X-100 and analysed by SDS-PAGE.
Transcription assays NIH 3T3 cells were transfected using the Superfect or Polyfect reagent (Qiagen, Valencia, CA) with 300 ng WWP-Luciferase (p21
Waf1/Cip1
), 300 ng pCMV5-RUNX1 (unless otherwise noted) or deletion constructs, and 300 ng pCMV5-secreted alkaline phosphatase (SEAP) plasmids (Lutterbach et al., 2000) . Empty pCMV5 was used as a control and pBluescript KS was added to bring the total amount of DNA in each sample to 1.5 mg. Luciferase activity was measured using the Luciferase Assay System (Promega, Madison, WI, USA) and normalized to SEAP activity.
DNA affinity chromatography
Jurkat or MEL cells were lysed with IsoHI buffer containing 0.2% Triton X-100 for 5 min on ice and the nuclei collected by centrifugation for 5 min at 1400 r.p.m. The cell pellet was washed one time before the nuclei were extracted in a buffer containing 0.5% Triton X-100, 0.1% SDS, 67 mM Tris-Cl, pH 6.8, 10 mM EDTA and 0.2 mM PMSF. The DNA was fragmented by sonication and the extract clarified by highspeed centrifugation. Biotinylated sense strand oligonucleotides containing perfect RUNX-binding sites (5 0 -biotin-AA TGTGGT TAA TGTGGT TAA TGTGGT TAA-3 0 ) were hybridized to the antisense oligonucleotide (5 0 -TTA ACCACA TTA ACCACA TTA ACCACA TT-3 0 , 500 mM of each oligonucleotide), or oligonucleotides derived from the B3URE (termed S2, JX and SB, in preparation), and bound to streptavidin-agarose (Sigma, St Louis, MO, USA) in suspension overnight in binding buffer (BB) (12 mM N-2-hydroxyethylpiperazine-N 0 -2-ethane sulfonic acid (HEPES), pH 7.9, 4 mM Tris, pH 7.9, 100 mM NaCl, 0.5 mM EDTA, 1 mM MgCl 2 ). For Jurkat cells, non-specific DNA binding was blocked by the addition of 100 mg of Salmon sperm DNA to 7 mg of nuclear extract. Proteins were allowed to mix with the resin overnight at 41C, the resin was poured into a column and the column washed two times with 10 column volumes of BB. Bound proteins were eluted with the nuclear lysis buffer supplemented with 1 M NaCl. The samples were concentrated to 100 ml and 20-30 ml analysed by immunoblot for RUNX1 and SUV39H1. For MEL cells, 500 mg of nuclear extract was incubated in 1 ml BB (1 Â BB, 20 mM HEPES, pH 7.9, 100 mM KCl, 1 mM MgCl 2 , 0.5 mM EDTA, 5% glycerol, 1 mM DTT), supplemented with 20 mg/ml poly(dI-dC), 5 mg/ml sonicated sperm DNA and 100 pmol biotinylated oligo. After 1-h incubation at 41C, a 100 ml slurry of streptavidin-agarose beads that were pre-blocked with 20 mg/ml salmon sperm DNA and 40 mg/ml acetated BSA in 1 Â BB were added and further incubated overnight. Beads were washed four times with 1 ml cold washing buffer (BB supplemented with 0.025% nucleoprotein (NP)-40) and directly analysed by Western blot analysis with the indicated antibodies.
Chromatin immunoprecipitation
ChIP analysis was carried out using a kit from Upstate Biotechnology following the manufacturer's procedure with slight modifications. After 1% formaldehyde crosslink of 1.0 Â 10 7 MEL cells, the cell pellet was suspended in lysis buffer (10 mM Tris-HCl, pH 8.0, 150 mM NaCl, 0.05% SDS, 0.5% Triton X-100, 0.5% NP-40, 0.1% sodium deoxycholate, 1 mM EDTA), and sonicated to shear the DNA to an average size of 500 base pairs. The chromatin was then pre-cleared with protein A-agarose and incubated with normal immunoglobulin G (IgG) or anti-Suv39h1 (Upstate Biotech) at 41C overnight. Purified DNA was resuspended in 20 ml of 0.1 Â TE and analysed by real-time quantitative PCR using SyBr Green.
